Namibia Business News API

{
    "totalArticles": 56,
    "articles": [
        {
            "id": "4932a4a5eb4d30c67edd8e46de2d9149",
            "title": "Global commercial insurance rates fall 4% in Q3 2025, marking the fifth consecutive quarterly decrease",
            "description": "Global commercial insurance rates fell, on average, by 4% in the third quarter of 2025, repeating the 4% decline recorded in Q2 2025.",
            "content": "New York, October 23, 2025 – According to the latest Global Insurance Market Index released today by Marsh, the world’s leading insurance broker and risk advisor and a business of Marsh McLennan (NYSE: MMC), global commercial insurance rates fell, on... [2303 chars]",
            "url": "https://www.marsh.com/en/about/media/global-commercial-insurance-rates-fall-4-percent-in-q3-2025.html",
            "image": "https://www.marsh.com",
            "publishedAt": "2025-10-22T23:09:29Z",
            "lang": "en",
            "source": {
                "id": "da0727b4f8e76a2ae8bac19034f6068e",
                "name": "Marsh",
                "url": "https://www.marsh.com"
            }
        },
        {
            "id": "15495806ba512815fbc1b258ca6709f5",
            "title": "AI in Biotechnology Research Report 2025-2030: Growing Need for More Effective Drug Discovery and Development Process and Shift to Personalized Medicine Bolster Growth - ResearchAndMarkets.com",
            "description": "The \"AI in Biotechnology: Global Markets\" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at...",
            "content": "DUBLIN--(BUSINESS WIRE)--The \"AI in Biotechnology: Global Markets\" report has been added to ResearchAndMarkets.com's offering.\nThe global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 bil... [5497 chars]",
            "url": "https://www.businesswire.com/news/home/20251022043068/en/AI-in-Biotechnology-Research-Report-2025-2030-Growing-Need-for-More-Effective-Drug-Discovery-and-Development-Process-and-Shift-to-Personalized-Medicine-Bolster-Growth---ResearchAndMarkets.com",
            "image": "https://mms.businesswire.com/media/20251022043068/en/2618113/22/logo.jpg",
            "publishedAt": "2025-10-22T20:02:00Z",
            "lang": "en",
            "source": {
                "id": "faa207db5381edc12400fbb5c91df94e",
                "name": "Business Wire",
                "url": "https://www.businesswire.com"
            }
        },
        {
            "id": "a17877fb69d231d0903fa071effeb6b6",
            "title": "Tetra Tech Announces Planned Dates for Fourth Quarter and Fiscal 2025 Results and Conference Call",
            "description": "Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, an...",
            "content": "PASADENA, Calif.--(BUSINESS WIRE)--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today the planned dates for its fourth quarter and... [574 chars]",
            "url": "https://www.businesswire.com/news/home/20251021880130/en/Tetra-Tech-Announces-Planned-Dates-for-Fourth-Quarter-and-Fiscal-2025-Results-and-Conference-Call",
            "image": "https://www.businesswire.com/bw-logo.png",
            "publishedAt": "2025-10-22T20:00:00Z",
            "lang": "en",
            "source": {
                "id": "faa207db5381edc12400fbb5c91df94e",
                "name": "Business Wire",
                "url": "https://www.businesswire.com"
            }
        }
    ]
}